by Patrick ➕follow (59) 💰tip ignore
« First « Previous Comments 14 - 53 of 79 Next » Last » Search these comments
The Mexican government is giving its citizens free Ivermectin in their covid kit. Maybe some of that common sense can make it's way through the border?
Ivermectin 62% Effective in Preventing COVID Mortality, 86% Effective in Preventing Infection, UK Doctor Says
Dr. Theresa Lawrie, MBBCh, Ph.D., in an interview Monday with America’s Frontline Doctors discussed her research on COVID treatments, including ivermectin. Lawrie, a physician, research analyst and consultant to the World Health Organization, urged listeners to take charge of their own health.
The Mexican government is giving its citizens free Ivermectin in their covid kit. Maybe some of that common sense can make it's way through the border?
https://t.me/greatreject/28585?source=patrick.net
Seriously, did the medical IQ drop by 100 points back in April of 2020 when common sense was chucked out the window in place of Faucism.
This is what it looks like when a government actually cares about its people and wants them to survive the pandemic.
Rin saysSeriously, did the medical IQ drop by 100 points back in April of 2020 when common sense was chucked out the window in place of Faucism.
Yeah it is like they all sold out to the dark lord.
Conclusion: In this large PSM study, regular use of ivermectin as a prophylactic agent was associated with significantly reduced COVID-19 infection, hospitalization, and mortality rates.
Woman Sneaks Ivermectin Into Hospital, Saves Husband's Life
Florida Doctor: Families Sneak Ivermectin to Loved Ones in Hospitals With COVID-19, See Improvement
By Nanette Holt January 26, 2022 Updated: January 26, 2022biggersmaller Print
A Florida doctor says families of loved ones hospitalized with COVID-19 are resorting to desperate measures when approved treatments have failed.
And when it’s not too late, some have seen tremendous success by sneaking medications prohibited by hospitals to patients, says Eduardo Balbona, an independent internist in Jacksonville.
He’s helped dozens of seriously ill patients recover using ivermectin and other drugs and supplements not officially approved in the treatment of COVID-19, he says.
Hospitals receive payments from the federal government for treating patients with COVID-19. But those payments are tied to their use of approved treatments only, as outlined in the CARES Act. When there’s nothing left to try under those protocols, families naturally research alternatives, Balbona says, often learning about treatments touted by independent physicians around the country.
Hoping to try anything that might work, families around the country have filed lawsuits asking judges to intervene.
In some cases, judges have ordered hospitals to allow the use of other treatments, such as ivermectin. Some of those seriously ill patients have recovered. In other cases, judges have sided with hospitals and declined the families’ requests to try.
Results: Of the 223,128 citizens of Itajaí considered for the study, a total of 159,561 subjects were included in the analysis: 113,845 (71.3%) regular ivermectin users and 45,716 (23.3%) non-users. Of these, 4,311 ivermectin users were infected, among which 4,197 were from the city of Itajaí (3.7% infection rate), and 3,034 non-users (from Itajaí) were infected (6.6% infection rate), with a 44% reduction in COVID-19 infection rate (risk ratio [RR], 0.56; 95% confidence interval (95% CI), 0.53-0.58; p < 0.0001). Using PSM, two cohorts of 3,034 subjects suffering from COVID-19 infection were compared. The regular use of ivermectin led to a 68% reduction in COVID-19 mortality (25 [0.8%] versus 79 [2.6%] among ivermectin non-users; RR, 0.32; 95% CI, 0.20-0.49; p < 0.0001). When adjusted for residual variables, reduction in mortality rate was 70% (RR, 0.30; 95% CI, 0.19-0.46; p < 0.0001). There was a 56% reduction in hospitalization rate (44 versus 99 hospitalizations among ivermectin users and non-users, respectively; RR, 0.44; 95% CI, 0.31-0.63; p < 0.0001). After adjustment for residual variables, reduction in hospitalization rate was 67% (RR, 0.33; 95% CI, 023-0.66; p < 0.0001).
Conclusion: In this large PSM study, regular use of ivermectin as a prophylactic agent was associated with significantly reduced COVID-19 infection, hospitalization, and mortality rates.
Japan's Kowa says ivermectin showed 'antiviral effect' against Omicron in research
Summary by Ground News
Japanese trading and pharmaceutical company Kowa Co Ltd said on Monday anti-parasite drug ivermectin showed an "antiviral effect" against Omicron and other variants of coronavirus in joint non-clinical research.
Yes, all powers not specifically given to the federal government by the Constitution are reserved to the states.
Yes, all powers not specifically given to the federal government by the Constitution are reserved to the states.
New Study on Ivermectin 'Should Convince Any Naysayer': Dr. Pierre Kory
February 02, 2022
Made with Beautifier
Original link from m.theepochtimes.com
A recently published study indicating the anti-parasitic ivermectin worked well as a prophylactic against the virus that causes COVID-19 should help sway critics of the drug, according to Dr. Pierre Kory, president of the Front Line COVID-19 Critical Care Alliance (FLCCC).
“That should convince any naysayer,” Kory told The Epoch Times’ “American Thought Leaders.” “What they found was astounding.”
The Brazilian city of Itajaí launched a program that gave ivermectin to any residents that wanted any. The period that was studied was from July 7, 2020, to December 2, 2020.
Researchers found that the program, which had over 100,000 residents participate, was linked to a 44 percent drop in COVID-19 cases.
Approximately 3.7 percent of ivermectin users contracted the illness during the trial period, compared to 6.6 percent of residents who didn’t take the drug.
The program was also associated with a statistically significant decrease in hospitalization and mortality.
The peer-reviewed study was published in Cureus on Jan. 15.
“Ivermectin MUST be considered as an option, particularly during outbreaks,” Dr. Flavio Cadegiani, one of the study’s authors and a founding member of FLCCC, told The Epoch Times in an email.
FLCCC focuses on early treatment of COVID-19, the disease caused by the CCP (Chinese Communist Party) virus. The group has recommended ivermectin since early 2020.
Kory said the lack of reporting on the study despite it being peer-reviewed highlights how some scientific developments are ignored by many media outlets and scientists.
“You would think this would lead major headlines everywhere. And yet, nothing. And this is not new, this censorship of this highly effective science and evidence around repurposed drugs. The censoring of it, it’s not new, it’s just getting more and more absurd. And it has to stop,” he said.
02/07/22
•
COVID › NEWS
Preventive Use of Ivermectin Reduced COVID Mortality by 90%, Study Found
A peer-reviewed study published last month found the prophylactic use of ivermectin reduced COVID mortality by 90% among more than 223,000 study participants in a town in Southern Brazil.
benadryl cures "long Fauci Flu"
Researchers used computational analyses to evaluate the performance of 10 medications against the Omicron variant, finding that ivermectin outperformed all of them, including nirmatrelvir (Paxlovid) a new drug from Pfizer that has cost taxpayers $5.29 billion and costs $529 per course of treatment.
Ivermectin lowers the viral load by inhibiting replication, reduces infection by 86% when used preventively, speeds recovery, protects against organ damage, lowers the risk of hospitalization and death and costs between $48 and $95 for a course of treatment depending on your location.
Early treatment lowers your risk of long COVID, which includes physical and mental health conditions. According to cardiologist Dr. Peter McCullough, 50% of those sick enough to be hospitalized have symptoms of long COVID.
Africa has a lower number of cases, severity of disease, hospitalizations and deaths than other areas of the world, which may be due to using prophylactic medications for endemic infections that have successfully treated COVID.
Yes, all powers not specifically given to the federal government by the Constitution are reserved to the states.
Mary Beth Pfeiffer is Banned by Twitter
For her overuse of the I-word, our writer joins Robert Malone, , and Brett Weinstein in Twitter Heaven.
Mary Beth Pfeiffer
Mar 2
No journalist has contributed more to the public and scientific debate on covid with her coverage of early treatments, including ivermectin, than Mary Beth Pfeiffer, and now Twitter has silenced her. But she has a new home on Telegram. Follow her there @marybethpf.
On Tuesday, March 1, 2022, I received an email from Twitter. It seems I had violated policy “on spreading misleading and potentially harmful information related to COVID-19.”
Without ceremony or meaningful due process, Twitter suspended my account, stripped me of 37,000 followers, and, just like that, silenced me.
I will not go quietly. For what it is worth, I will have the last word.
My offending tweet said, simply, “Pharma is afraid of ivermectin. It should be.”
I then recommended, and linked to, an article by Dr. Steven Phillips, which I said was on “the evidence in favor of IVM—from Covid to Cancer. It explains a lot.”
Phillips’ well-researched piece laid out the case for ivermectin, much as I had in more than two dozen articles since Oct. 1, 2020. My favorite headline, which Twitter also called misinformation: “Not Using Ivermectin, One Year In, Is Unethical And Immoral.” That time, the lockout was temporary. Now, it’s for good.
Combine with 10,000u Vit D and Quercetin, even better.
Combine Ivermectin, Quercetin Phytosome, Allisure Allicin, R-Lipoic Acid, Vit D, & Zinc and watch that virus run for its life.
Ivermectin Is Associated with Decreased Mortality as well as improved outcomes, more data on myocarditis after vaccination.
Not holding my breath for apologies from medical boards, legacy and social media
Robert W Malone MD, MS
5 hr ago
Treatment with Ivermectin Is Associated with Decreased Mortality in COVID-19 Patients: Analysis of a National Federated Database
International Journal of Infectious Diseases Volume 116, Supplement, March 2022
Abstract Highlights:
Comparing ivermectin versus remdesivir with an endpoint of reduced mortality, using a large national database.
Patients groups were controlled for (matched) both comorbidities (unlike that NY Board of health pediatric vaccine study) as well as treatments that may affect COVID-19 survival outcomes: age, gender, race, ethnicity, nicotine use diabetes mellitus, obesity, chronic lower respiratory disease, ischemic heart diseases, tocilizumab, glucocorticoids, or ventilator use.
After using propensity score matching and adjusting for potential confounders, ivermectin was associated with reduced mortality vs remdesivir p<0.0001.
« First « Previous Comments 14 - 53 of 79 Next » Last » Search these comments
patrick.net
An Antidote to Corporate Media
1,228,252 comments by 14,681 users - mell, RC2006 online now